DIMPLE DESAI: Open Payments
NPI 1497085930 · ZEPHYRHILLS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,681 in 133 payments from 15 companies in 2025. Trend: 2023 $2,863 · 2024 $2,487 · 2025 $2,681
Food & beverage: $2,681
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $791 |
| Amgen Inc. | 28 | $476 |
| UCB, Inc. | 22 | $385 |
| Janssen Biotech, Inc. | 13 | $248 |
| GlaxoSmithKline, LLC. | 12 | $194 |
| Lilly USA, LLC | 7 | $175 |
| Novartis Pharmaceuticals Corporation | 4 | $115 |
| PFIZER INC. | 5 | $100 |
| ANI Pharmaceuticals, Inc. | 3 | $69 |
| Radius Health, Inc. | 2 | $32 |
Products named: RINVOQ, Bimzelx, TREMFYA, SKYRIZI, BENLYSTA, TALTZ, OTEZLA, TAVNEOS.
Industry payments across FL — which companies pay providers there.
